US Drug Recall Register
Class I · High risk Terminated Initiated Mar 29, 2022 (4 years ago)

IDArubicin Hydrochloride Injection USP 5gm/5mL (1mg/mL) for intravenous use, 5mL Single…

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Presence of Particulate Matter: Product was found to contain silica and iron oxide

What was recalled

IDArubicin Hydrochloride Injection USP 5gm/5mL (1mg/mL) for intravenous use, 5mL Single Dose Vial, Rx Only, Teva Pharmaceuticals, USA, Inc., North Wales, PA 19454, NDC 0703-4154-11.

Recalling firm
Teva Pharmaceuticals USA Inc
NDC code
0703-4154-11
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0765-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Chloride recalls

See all